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Abstract
Background Vitiligo is an acquired depigmentation of the
skin characterized by white spots with well-defined margins,
causing psychological stress in patients due to cosmetic
concerns. We examined 27 patients who underwent vitiligo
treatment using autologous cultured keratinocytes.
Methods The study comprised 20 patients with segmental
vitiligo and seven patients with generalized vitiligo, and they
were followed up for at least 1 year postoperatively. In all 27
cases, topical steroid or ultraviolet therapy had been previ-
ously performed by dermatologists, but this treatment had
been ineffective. The patients' vitiligo had stabilized. The
patients were treated using keratinocytes obtained from pri-
mary culture using Green's techniques or from first passage.
Dispase treatment was used to detach the stratified cultured
epithelial sheets from their culture dishes. The detached
sheets shrank to approximately one half to two thirds of their
original size on the culture dish. After the recipient site was
completely epithelialized, the skin was exposed to sunlight.
Results For patients with segmental vitiligo, 12 had a good
therapeutic outcome (90 % or more repigmentation) after the
first surgery. This number increased to 14 when patients with
multiple surgeries were included. There were six patients
with fair outcomes (50–90 % repigmentation), and no pa-
tients with poor outcomes (50 % or less repigmentation). For
patients with generalized vitiligo, no patients had a good
outcome despite multiple surgeries. There were three
patients with fair outcomes, and four patients with no change
outcomes.
Conclusions Cultured keratinocyte grafting was a more effec-
tive treatment for segmental vitiligo than for generalized vitiligo.
Level of Evidence: Level IV, therapeutic study.
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Introduction
Vitiligo is an acquired depigmentation of the skin character-
ized by white spots with well-defined margins, causing psy-
chological stress in patients due to cosmetic concerns. In
1993, we began to treat vitiligo using autologous cultured
keratinocytes. In 1997, we treated two patients with segmen-
tal vitiligo and two patients with generalized vitiligo and
reported no significant difference in the therapeutic outcome
[1]. By 2011, a total of 30 vitiligo patients had undergone
this treatment and 27 were examined in follow-up. We report
here the observed difference in therapeutic outcomes be-




Autologous cultured keratinocytes were used to treat 30
vitiligo patients between February 1993 and March 2011.
Among these patients, 20 males and seven females (average
age, 24.7 years old) were followed up for at least 1 year
postoperatively (average follow-up period, 1.9 years). Seg-
mental vitiligo was present in 20 patients, and seven had
generalized vitiligo (Table 1). In all 27 patients, topical
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steroid or ultraviolet therapy had been performed by derma-
tologists, but the treatments had been ineffective. The pa-
tient's vitiligo was stable.
Cultured keratinocytes
The donor site for keratinocyte harvest was the abdomen or
another healthy site selected for its location, i.e., near the
graft site or a few centimeters away from the lesion. The
method of culturing epithelial cells was the same used in our
previous report in which lethally irradiated 3T3-J2 cells and
Green's culture techniques were used [1, 2]. Keratinocytes
were obtained from primary culture or from first passage.
Dispase treatment was used to detach stratified cultured
epithelial sheets from their culture dishes; the detached
sheets shrank to approximately one half to two thirds of their
original size on the culture dish and subsequently were
attached to carriers. This process enabled the number of
melanocytes per unit area to increase in the cultured epithe-
lium before graft transplantation.
Cultured keratinocyte grafting
As in our previous report, the vitiliginous area was de-
epithelialized using motor-driven, abrasive, serrated wheels.
A carrier was used to transfer the cultured epithelium and
Table 1 Treatment of vitiligo
Case
No.
Age Gender Type No. of
operations





1 9 M S 1 Face Forehead, palpebra 320 6.5 Good
2 9 M S 2 Abdomen Chest, upper limb 780 4 Good
3 40 F S 1 Abdomen Neck, axilla 600 1 Good
4 13 F S 1 Abdomen Forehead, palpebra 300 1 Good
5 38 M S 1 Abdomen Cheek, lip, neck 480 3 Good
6 19 F S 1 Face Cheek, neck 360 1 Good
7 24 M S 1 Abdomen Forehead, palpebra 300 1 Good
8 21 M S 1 Face Face 180 1 Good
9 16 M S 1 Face Face 480 2 Good
10 12 M S 1 Face Palpebra 30 3 Good
11 43 M S 1 Inguen Penis 60 1.5 Good
12 20 M S 2 Upper
thigh
Upper & lower thigh 1,200 4 Good
13 23 F S 1 Abdomen Forehead, palpebra 140 1 Good
14 20 M S 1 Abdomen Scrotum 180 1 Good
15 17 F S 3 Abdomen Abdomen 2,040 3.5 Fair
16 24 M S 1 Abdomen Cheek 70 1 Fair
17 18 M S 1 Upper
thigh
Upper thigh 1,200 1.5 Fair
18 38 F S 2 Abdomen Abdomen 1,620 2.5 Fair
19 14 M S 1 Abdomen Face, neck, chest 900 1 Fair
20 22 M S 1 Abdomen Cheek 215 1 Fair
21 29 M G 1 Abdomen Neck, chest 300 2.5 Fair
22 22 M G 2 Abdomen Neck, abdomen, lower
thigh
780 1 Fair
23 23 M G 3 Abdomen Abdomen 1,320 3.5 Fair
24 48 M G 1 Abdomen Lip, hand, abdomen 840 1 No
change
25 32 M G 1 Abdomen Chin, hand, abdomen 1,200 1 No
change
26 30 M G 1 Abdomen Chin, hand, abdomen 600 1 No
change
27 42 F G 1 Abdomen Neck, hand 540 1 No
change
M male, F female, S segmental type, G generalized type
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grafting was performed [1]. The graft site was dressed with
Adaptic® (Johnson & Johnson Medical Inc., Arlington, TX)
cellulose acetate fabric impregnated with petroleum jelly.
One week after grafting, the Adaptic® dressing was removed
and the site was redressed with steroid ointment-impregnated
Adaptic® for 2 to 3 weeks postoperatively.
Management after grafting
The recipient site was completely epithelialized between 10
and 14 days postoperatively; steroid ointment was applied
twice daily after complete epithelialization. The grafted mela-
nocytes were then activated by ultraviolet radiation. Sun ex-
posure commenced 1 week after completion of epithelializa-
tion (3 weeks postoperatively). The skin was exposed to indi-
rect sunlight, beginning with approximately 5–10 min of treat-
ment per day. Subsequently, the irradiation time was extended
to 30 min to 1 h. The patient was prohibited from receiving
prolonged direct sunlight for 1 year after grafting to prevent
blistering of the graft site. Repigmentation generally began to
occur approximately 3 months postoperatively. Sun exposure
treatment was used for at least 6 months. The graft site of each
patient was evaluated at their final examination during the
follow-up period. A good outcome was defined as 90 % or
more repigmentation, a fair outcome as 50–90 %, a poor
outcome as 50 % or less repigmentation, and no change
outcome. For statistical analysis, each condition was converted
to a numerical value according to the following scale: no
change, 0; poor, 1; fair, 2; and good, 3. After converting to
ordinal data, we used the nonparametric Mann–WhitneyU test
and investigated the difference in treatment effect between
segmental and generalized types. The analysis was performed
with IBM SPSS statistics 21 (IBM, Armonk, NY, USA).
Results
Among segmental vitiligo patients, 12 of 20 had a good
therapeutic outcome after the first surgery (case 1, Fig. 1).
When patients who achieved a good outcome after multiple
surgeries were included, this number increased to 14 (case 2,
Fig. 2). There were six patients with fair outcomes (case 18,
Fig. 1 Treatment of segmental
vitiligo in case 5. a Before
surgery. b Vitiliginous areas
were de-epithelialized and the
cultured epithelia were grafted.
c Three years postoperatively.
The outcome was assessed as
good
Eur J Plast Surg (2013) 36:651–656 653
Fig. 3), and no patients with poor and no change outcomes.
Of the seven generalized vitiligo patients, none had a good
outcome despite multiple surgeries. There were three pa-
tients with fair outcomes (case 21, Fig. 4), and four patients
with no change outcomes (case 24, Fig. 5) (Table 1). We
confirmed a highly statistically significant difference in treat-
ment effect between segmental and generalized types
(p=0.000). None of the 27 patients experienced a problem
related to wound healing, and there was no hypertrophic
scarring at the treated sites.
Discussion
In 1993, we began vitiligo treatment using autologous cul-
tured epithelium [1] after confirming the presence of dopa-
positive melanocytes with dendritic processes in the basal
layer of the epithelium. The desired ratio was approximately
one such melanocyte to 14 basal cells. In our previous study,
the skin showed histologically improved color at the post-
operative follow-up visits. Two weeks after grafting, dopa-
positive melanocytes survived but melanistic granules were
not yet observable. Six weeks postoperatively, there were
melanistic granules present, although fewer than are found in
normal epithelium. By 6 to 8 months postoperatively, there
were dopa-positive melanocytes and melanistic granules at
levels similar to those found in normal epithelium. Dopa-
positive melanocytes were also present in hair follicles; thus,
the color of the eyebrow was also improved. At 3 years
postoperatively, dopa-positive melanocytes and melanistic
granules were arranged in the same pattern as in the normal
epithelium. Thus, we demonstrated the effectiveness of au-
tologous cultured keratinocyte treatment and the study was
continued with more patients [1].
When the initial two segmental vitiligo cases and two
generalized vitiligo cases were evaluated, the treatment
appeared to yield similar effectiveness in both types of the
disease. However, in our present study of 27 cases, the
therapeutic outcomes differed between these types. In some
segmental vitiligo cases, such as the patient in case 2, the
outcome was poor after the first surgery but improved to
good after the second surgery. There can also be generalized
vitiligo cases that can achieve a good outcome after multiple
surgeries. Twelve segmental vitiligo cases, but no general-
ized vitiligo cases, had a good outcome after one surgery.
These results indicated a difference in the therapeutic out-
come of cultured keratinocyte grafting between the two types
of vitiligo.
The autoimmune response is thought to be more virulent
in generalized vitiligo cases compared with segmental vitili-
go cases [3]. The major cause of the difference in therapeutic
outcome might be nonfunctioning melanocytes in the grafted
cultured epithelium; these melanocytes having been victim-
ized by the autoimmune response.
The number of melanocytes is known to decrease with
repeated passage of the cultured epithelium [4]. Therefore,
either a primary culture or a culture obtained after first
passage is used for transplantation in vitiligo. If a second
passage is performed, a sufficient amount of cultured epithe-
lium can be obtained. Thus, a second passage is frequently
used in treatment of extensive burns, but it is unsuitable for
vitiligo treatment [5]. Unlike treatment for extensive burns,
vitiligo treatment involves a cultured epithelium that has
been detached from a culture dish using dispase and that
therefore shrinks to approximately one half to two thirds of
Fig. 2 Treatment of segmental vitiligo in case 2. a Before the first
surgery. b Two and a half years after the second surgery. The outcome
was assessed as good
Fig. 3 Treatment of segmental
vitiligo in case 18. a Before
surgery. b Two years and
9 months after treatment of the
left abdomen. The outcome was
assessed as fair
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its original size on the culture dish. This process enables the
number of melanocytes per unit area to increase before
grafting. However, if extensive grafting is required, it is
difficult to decide on the acceptable degree of shrinkage. In
addition, it is necessary to have a slight overlap when
grafting to prevent gap formation between cultured epithelial
sheets and to prevent uneven pigmentation. If the grafting
site is extensive, the degree of overlap can become insuffi-
cient. Cases 2 and 12 were segmental vitiligo patients who
had extensive affected areas; they both required a second
surgery to achieve a good outcome.
Cultured epithelium is known to maintain characteristics
of the donor-site epithelium [6]. Thus, for a palmar graft site,
a donor site is required to have a thick horny layer, but
without melanocytes; for such a graft, the plantar epithelium
of the foot is used. There has not been a paper to date which
reported on whether the donor site should be located near the
recipient site in the treatment of facial vitiligo. When we first
began this particular treatment, we treated facial vitiligo
using skin harvested from pre and postauricular regions near
the affected site. Since the first goal of vitiligo treatment is to
obtain pigmentation, we currently harvest abdominal epithe-
lium, even for grafting to treat facial vitiligo. Non-sun ex-
posed epithelium is known to become well pigmented if it is
grafted onto the face [7]. A similar effect is expected for
cultured epithelium from the abdomen.
All 27 subjects in our study were Asians. Although
Asians are more prone to hypertrophic scarring compared
with Caucasians [8, 9], none of our patients developed such
complications after treatment. When the vitiliginous area is
de-epithelialized to a shallow depth and the cultured epithe-
lium is transplanted, rapid wound healing can be achieved.
Thus, we considered this treatment to be safe, even in Asians
who are prone to prominent scarring. All our subjects had
previously undergone topical steroid or ultraviolet therapy
that had proved ineffective with no repigmentation. Thus, all
subjects with the therapeutic outcome of fair or better were
satisfied with the improvement in color after our treatment.
Felsten et al. [10] reviewed the background and efficacy of
different surgical therapies for vitiligo, including blister graft,
Fig. 4 Treatment of generalized
vitiligo in case 21. a Before
surgery. b Two and a half years
after treatment of the neck and
chest. The outcome was assessed
as fair
Fig. 5 Treatment of generalized
vitiligo in case 24. a Before
surgery. b One year after
treatment of the upper and lower
lips, abdomen, and both hands
(not shown). The outcome was
assessed as no change
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split-thickness skin graft, punch graft, and autologous mela-
nocyte suspension transplant. For transplantation therapies
other than those using autologous cultured keratinocytes,
many reports have been published. These treatments have
included transplantation of cultured autologous melanocytes,
keratinocyte/melanocyte cocultures, noncultured suspension
of epidermal cells, and noncultured autologous epidermal
suspensions produced using a ReCell® system [11, 12]. Many
treatment methods are therefore available for vitiligo, but there
has not yet been an optimal treatment identified. Thus, there
have been efforts to develop new treatments, such as those
using coculture of melanocytes with adipose-derived stem
cells to inhibit melanocyte differentiation and to promote
melanocyte proliferation and migration [13]. In addition, re-
search on vitiligo treatment has become multifaceted and
includes the development of effective carrier dressings for
cultured cell delivery to improve therapeutic outcomes [14].
In our previous study, we examined the outcomes of four
vitiligo patients who were treated using autologous cultured
keratinocytes. We reported no significant difference in the
therapeutic outcome between patients with segmental vitiligo
and those with generalized vitiligo. In our present study, we
examined 27 patients and found that patients with segmental
vitiligo had superior therapeutic outcomes compared with
those suffering from generalized vitiligo. This study using
autologous cultured keratinocytes involved a sufficiently large
number of cases to determine an outcome difference. The
effectiveness of new treatments can be examined by compar-
ing their results with those of our treatment. Our results might
contribute to the development of new treatments for vitiligo.
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